poster
Understanding where a drug candidate goes in the body, and how much radiation exposure it could mean for humans, is central to planning a successful hAME study. This poster, presented at ISSX 2026, shows how Frontage’s QWBA and Radiation Dosimetry Center of Excellence combines quantitative tissue distribution data with ICRP- and MIRD-based dosimetry projections. Download it to see the workflow, capabilities, and regulatory considerations behind our approach.
Register to gain access to gated resources.
"*" indicates required fields
Frontage Laboratories websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies, and their use, please see our privacy policy.
Websites store cookies to enhance functionality and personalise your experience. You can manage your preferences, but blocking some cookies may impact site performance and services.
Essential cookies enable basic functions and are necessary for the proper function of the website.
